These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

641 related items for PubMed ID: 11152285

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Protein kinase B phosphorylation of PIKfyve regulates the trafficking of GLUT4 vesicles.
    Berwick DC, Dell GC, Welsh GI, Heesom KJ, Hers I, Fletcher LM, Cooke FT, Tavaré JM.
    J Cell Sci; 2004 Dec 01; 117(Pt 25):5985-93. PubMed ID: 15546921
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Separation of insulin signaling into distinct GLUT4 translocation and activation steps.
    Funaki M, Randhawa P, Janmey PA.
    Mol Cell Biol; 2004 Sep 01; 24(17):7567-77. PubMed ID: 15314166
    [Abstract] [Full Text] [Related]

  • 8. An inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes.
    Sweeney G, Somwar R, Ramlal T, Volchuk A, Ueyama A, Klip A.
    J Biol Chem; 1999 Apr 09; 274(15):10071-8. PubMed ID: 10187787
    [Abstract] [Full Text] [Related]

  • 9. Activators of AMP-activated protein kinase enhance GLUT4 translocation and its glucose transport activity in 3T3-L1 adipocytes.
    Yamaguchi S, Katahira H, Ozawa S, Nakamichi Y, Tanaka T, Shimoyama T, Takahashi K, Yoshimoto K, Imaizumi MO, Nagamatsu S, Ishida H.
    Am J Physiol Endocrinol Metab; 2005 Oct 09; 289(4):E643-9. PubMed ID: 15928020
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. MEK inhibitors impair insulin-stimulated glucose uptake in 3T3-L1 adipocytes.
    Harmon AW, Paul DS, Patel YM.
    Am J Physiol Endocrinol Metab; 2004 Oct 09; 287(4):E758-66. PubMed ID: 15172888
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nigericin inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes.
    Chu CY, Kao YS, Fong JC.
    J Cell Biochem; 2002 Oct 09; 85(1):83-91. PubMed ID: 11891852
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. 4-Bromocrotonic acid enhances basal but inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes.
    Leu SJ, Chai SP, Kwok CF, Fong JC.
    Biochem Biophys Res Commun; 1998 Mar 06; 244(1):11-4. PubMed ID: 9514876
    [Abstract] [Full Text] [Related]

  • 18. Arsenite stimulated glucose transport in 3T3-L1 adipocytes involves both Glut4 translocation and p38 MAPK activity.
    Bazuine M, Ouwens DM, Gomes de Mesquita DS, Maassen JA.
    Eur J Biochem; 2003 Oct 06; 270(19):3891-903. PubMed ID: 14511371
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.